Movement Disorders

What happens before the demyelinating lesions of MS appear? Does smoking confer protection against Parkinson disease? How is NMDA receptor-associated disease reversed? Here are 4 fine papers from 2014 that set out to answer these questions.

Parkinson and other neurodegenerative diseases are hard to distinguish. Surface-based MRI shows promise as a diagnostic tool.

Get to the root of the latest research findings on nervous system disorders and test your brainpower with this quick 5-question quiz.

The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.

These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.

Up until now, these treatments have not produced promising efficacy results in clinical trials. MRI could show the way.

Why ask patients to “spit in a cup”? Statistically significant protein differences have been found in Alzheimer disease saliva, and trends have been observed for Parkinson disease.

Serum testing for NMDAR and other autoantibodies is fraught with pitfalls, and careful clinical consideration is important.

In this podcast, Ann Scher, PhD, lead author in a recently published study, gives a succinct overview of the details and briefly discusses what the findings may suggest.

Tango may be not only a vibrant dance of passion but also a therapeutic one. Symptoms and socialization may be improved.

The rate of diagnostic accuracy is lower in early disease and higher in later disease and is improved by medication response and other factors.

The remarkable coffee bean is associated with reduced prevalence of several diseases, including Parkinson disease, Alzheimer disease, cancer, cardiovascular disease, and diabetes.

This study indicates that your mother was right about eating your fruits and vegetables: results suggest that eating some foods and avoiding others could be a nutrient prescription for Parkinson disease.

The chair of Allegheny Health Network’s Neurosciences Institute discussed a groundbreaking phase 3 trial evaluating the safety and efficacy of deep brain stimulation in patients with Alzheimer disease. [WATCH TIME: 5 minutes]